Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,375 | 504 | 77.1% |
| Consulting Fee | $2,800 | 1 | 17.4% |
| Education | $756.84 | 47 | 4.7% |
| Travel and Lodging | $124.45 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $3,551 | 34 | $0 (2024) |
| Galderma Laboratories, L.P. | $2,261 | 69 | $0 (2024) |
| Journey Medical Corporation | $1,608 | 16 | $0 (2024) |
| Janssen Biotech, Inc. | $1,519 | 82 | $0 (2023) |
| ABBVIE INC. | $823.48 | 55 | $0 (2024) |
| Dermavant Sciences, Inc. | $706.86 | 39 | $0 (2024) |
| Lilly USA, LLC | $683.28 | 31 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $549.34 | 29 | $0 (2024) |
| Allergan Inc. | $480.11 | 5 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $449.76 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,541 | 92 | Dermavant Sciences, Inc. ($492.49) |
| 2023 | $4,504 | 86 | Sun Pharmaceutical Industries Inc. ($3,076) |
| 2022 | $1,361 | 58 | Janssen Biotech, Inc. ($292.41) |
| 2021 | $1,754 | 62 | Galderma Laboratories, L.P. ($686.69) |
| 2020 | $396.10 | 25 | Janssen Biotech, Inc. ($153.67) |
| 2019 | $1,368 | 50 | Galderma Laboratories, L.P. ($450.41) |
| 2018 | $2,141 | 110 | Galderma Laboratories, L.P. ($588.45) |
| 2017 | $1,992 | 70 | Allergan Inc. ($480.11) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $13.00 | General |
| Category: Dermatology | ||||||
| 12/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.42 | General |
| Category: IMMUNOLOGY | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $5.58 | General |
| Category: DERMATOLOGY | ||||||
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: DERMATOLOGY | ||||||
| 11/21/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $98.01 | General |
| Category: Dermatology | ||||||
| 11/21/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $20.21 | General |
| Category: Dermatology | ||||||
| 11/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $8.82 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $112.58 | General |
| Category: Dermatology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Dermatology | ||||||
| 10/28/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $1.30 | General |
| Category: Dermatology | ||||||
| 10/26/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $199.22 | General |
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $140.44 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $97.23 | General |
| Category: DERMATOLOGY | ||||||
| 10/21/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $7.15 | General |
| Category: Dermatology | ||||||
| 10/10/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 10/09/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.43 | General |
| Category: Dermatology | ||||||
| 10/08/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $28.38 | General |
| Category: DERMATOLOGY | ||||||
| 10/02/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $25.51 | General |
| Category: Immunology | ||||||
| 09/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Dermatology | ||||||
| 09/18/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $28.68 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.22 | General |
| 09/10/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: DERMATOLOGY | ||||||
| 09/03/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $23.86 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 2,210 | 3,895 | $484,137 | $152,271 |
| 2022 | 12 | 2,218 | 4,054 | $476,363 | $148,212 |
| 2021 | 12 | 2,267 | 3,823 | $360,690 | $147,911 |
| 2020 | 18 | 2,429 | 3,958 | $377,339 | $155,270 |
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 780 | 1,196 | $211,692 | $68,497 | 32.4% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 395 | 519 | $67,470 | $20,624 | 30.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 194 | 224 | $48,832 | $16,682 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 76 | 96 | $24,000 | $8,367 | 34.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 113 | 113 | $24,860 | $7,798 | 31.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 169 | 206 | $22,660 | $7,570 | 33.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 93 | 104 | $20,592 | $6,575 | 31.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 262 | 1,302 | $31,248 | $6,093 | 19.5% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 70 | 70 | $9,940 | $3,170 | 31.9% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 22 | 26 | $10,530 | $2,878 | 27.3% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 17 | 20 | $5,720 | $2,021 | 35.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 19 | 19 | $6,593 | $1,997 | 30.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 775 | 1,150 | $201,830 | $64,849 | 32.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 388 | 535 | $68,680 | $20,957 | 30.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 192 | 227 | $49,009 | $16,984 | 34.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 122 | 122 | $26,504 | $8,211 | 31.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 189 | 220 | $23,795 | $8,091 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 77 | 100 | $24,700 | $7,872 | 31.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 264 | 1,480 | $35,520 | $6,924 | 19.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 95 | 99 | $19,461 | $6,358 | 32.7% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 73 | 73 | $10,211 | $2,709 | 26.5% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 13 | 15 | $5,205 | $2,011 | 38.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 15 | 18 | $7,290 | $1,923 | 26.4% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2022 | 15 | 15 | $4,158 | $1,324 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 717 | 1,036 | $138,824 | $60,237 | 43.4% |
About Dr. Conley Engstrom, MD
Dr. Conley Engstrom, MD is a Dermatology healthcare provider based in Westlake, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518949551.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Conley Engstrom, MD has received a total of $16,057 in payments from pharmaceutical and medical device companies, with $2,541 received in 2024. These payments were reported across 553 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($12,375).
As a Medicare-enrolled provider, Engstrom has provided services to 9,124 Medicare beneficiaries, totaling 15,730 services with total Medicare billing of $603,663. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westlake, OH
- Active Since 11/16/2005
- Last Updated 02/06/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1518949551
Products in Payments
- ILUMYA (Biological) $3,435
- TREMFYA (Drug) $835.55
- EPIDUO FORTE (Drug) $793.55
- VTAMA (Drug) $706.86
- AKLIEF (Drug) $672.55
- TALTZ (Drug) $569.25
- Sotyktu (Drug) $449.76
- COSENTYX (Biological) $389.21
- Tremfya (Drug) $365.52
- ACZONE (Drug) $354.83
- Ceracade (Drug) $332.15
- Humira (Biological) $300.16
- EUCRISA (Drug) $296.43
- ENSTILAR (Drug) $278.58
- OPZELURA (Drug) $255.37
- SKYRIZI (Biological) $242.61
- STELARA (Biological) $224.07
- RINVOQ (Biological) $220.72
- Exelderm (Drug) $218.68
- SOOLANTRA (Drug) $210.86
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westlake
Michael Reep, Md, MD
Dermatology — Payments: $426,210
Paul Hazen, Md, MD
Dermatology — Payments: $82,388
Karen Turgeon, Md, MD
Dermatology — Payments: $6,374
Aziza Wahby, Do, DO
Dermatology — Payments: $2,223
Dr. Adrienne Callahan, M.d, M.D
Dermatology — Payments: $2,020
Kelly Scarberry
Dermatology — Payments: $1,296